New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Stem Cell Transplant Techniques Evolving to Include More Patient Populations

Stem Cell Transplant Techniques Evolving to Include More Patient Populations

June 20, 2017Gina ColumbusTsiporah B. Shore, MD, discusses some of these newer advancements related to stem cell transplantation and the challenges with including patients in ethnic populations.Tsipor
World medicine November 21,2023
Stem Cell Transplant Techniques Evolving to Include More Patient Populations

Stem Cell Transplant Techniques Evolving to Include More Patient Populations

June 20, 2017Gina ColumbusTsiporah B. Shore, MD, discusses some of these newer advancements related to stem cell transplantation and the challenges with including patients in ethnic populations.Tsipor
World medicine November 21,2023
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8, 2018Caroline SeymourNoa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.Noa Biran, MDPreliminary pilot data presented at the
World medicine November 21,2023
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8, 2018Caroline SeymourNoa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.Noa Biran, MDPreliminary pilot data presented at the
World medicine November 21,2023
Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

August 31, 2012Jill SteinLenalidomide used continuously after autologous hematopoietic stem cell transplantation significantly prolonged the time to disease progression and overall survival in patient
World medicine November 21,2023
Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

August 31, 2012Jill SteinLenalidomide used continuously after autologous hematopoietic stem cell transplantation significantly prolonged the time to disease progression and overall survival in patient
World medicine November 21,2023
Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

May 22, 2017Angelica WelchDaniel J. Landsburg, MD, discusses the management of patients with double-hit lymphoma who have achieved remission.Daniel J. Landsburg, MDFor patients with double-hit lymphom
World medicine November 21,2023
Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

May 22, 2017Angelica WelchDaniel J. Landsburg, MD, discusses the management of patients with double-hit lymphoma who have achieved remission.Daniel J. Landsburg, MDFor patients with double-hit lymphom
World medicine November 21,2023
Stem Cell Research Aims to Further Personalize Lung Cancer Care

Stem Cell Research Aims to Further Personalize Lung Cancer Care

August 8, 2017Gina ColumbusTushar Desai, MD, discusses his research in stem cells and why discovering which cells have the potential to form lung cancer is significant to the treatment paradigm.Tushar
World medicine November 21,2023
Stem Cell Research Aims to Further Personalize Lung Cancer Care

Stem Cell Research Aims to Further Personalize Lung Cancer Care

August 8, 2017Gina ColumbusTushar Desai, MD, discusses his research in stem cells and why discovering which cells have the potential to form lung cancer is significant to the treatment paradigm.Tushar
World medicine November 21,2023
Stem Cells Create a Therapeutic Niche

Stem Cells Create a Therapeutic Niche

October 18, 2014Surabhi Dangi-Garimella, PhDStem cell therapy has gained increasing traction in various therapeutic areas, from cancer to diabetes to ocular regeneration.Stem cell therapy has gained i
World medicine November 21,2023
Stem Cells Create a Therapeutic Niche

Stem Cells Create a Therapeutic Niche

October 18, 2014Surabhi Dangi-Garimella, PhDStem cell therapy has gained increasing traction in various therapeutic areas, from cancer to diabetes to ocular regeneration.Stem cell therapy has gained i
World medicine November 21,2023
Limited Availability of Non-Caucasian Stem Cell Donors: A Growing Problem?

Limited Availability of Non-Caucasian Stem Cell Donors: A Growing Problem?

April 8, 2014Prerna Mewawalla, MDTo address the challenge of the limited availability of stem cell donors in non-Caucasians, it is vital that we increase awareness through more campaigns that are targ
World medicine November 21,2023
Limited Availability of Non-Caucasian Stem Cell Donors: A Growing Problem?

Limited Availability of Non-Caucasian Stem Cell Donors: A Growing Problem?

April 8, 2014Prerna Mewawalla, MDTo address the challenge of the limited availability of stem cell donors in non-Caucasians, it is vital that we increase awareness through more campaigns that are targ
World medicine November 21,2023
Herpes Zoster Vaccine Elicits Robust Immune Response in HSCT Patients

Herpes Zoster Vaccine Elicits Robust Immune Response in HSCT Patients

February 24, 2019Onclive TeamTwo doses of adjuvanted recombinant zoster vaccine following autologous hematopoietic stem cell transplant led to rapid and durable cell-mediated immune responses, results
World medicine November 21,2023
Herpes Zoster Vaccine Elicits Robust Immune Response in HSCT Patients

Herpes Zoster Vaccine Elicits Robust Immune Response in HSCT Patients

February 24, 2019Onclive TeamTwo doses of adjuvanted recombinant zoster vaccine following autologous hematopoietic stem cell transplant led to rapid and durable cell-mediated immune responses, results
World medicine November 21,2023
Eltrombopag Approved in Europe for Severe Aplastic Anemia

Eltrombopag Approved in Europe for Severe Aplastic Anemia

September 2, 2015Silas InmanThe European Commission has approved eltrombopag as a treatment for adult patients with severe aplastic anemia who are refractory to immunosuppressive therapy or are heavil
World medicine November 21,2023
Eltrombopag Approved in Europe for Severe Aplastic Anemia

Eltrombopag Approved in Europe for Severe Aplastic Anemia

September 2, 2015Silas InmanThe European Commission has approved eltrombopag as a treatment for adult patients with severe aplastic anemia who are refractory to immunosuppressive therapy or are heavil
World medicine November 21,2023
Cancer Stem Cells Coming Into Sharper Focus

Cancer Stem Cells Coming Into Sharper Focus

November 11, 2015Jane de Lartigue, PhDParticular progress has been made in the development of small-molecule inhibitors of key signaling pathways that are responsible for the unique characteristics of
World medicine November 21,2023
Cancer Stem Cells Coming Into Sharper Focus

Cancer Stem Cells Coming Into Sharper Focus

November 11, 2015Jane de Lartigue, PhDParticular progress has been made in the development of small-molecule inhibitors of key signaling pathways that are responsible for the unique characteristics of
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com